ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,564.41
1.08%
US Tech 100
19,282.40
1.44%
Dow Jones
40,421.36
0.33%
Brent Oil
81.585
-0.84%
Bitcoin
67,964.65
-0.28%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Akili Inc (AKLI)

  7. Akili Inc (AKLI) News

AKLI

Akili (AKLI)

Akili Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AKLI
DateTimeSourceHeadlineSymbolCompany
06/18/20244:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKLIAkili Inc
06/18/20244:01PMBusiness WireAkili Announces FDA Authorization of EndeavorOTC, the First FDA Clearance of a Digital Treatment for Adults with ADHD Through a Video GameNASDAQ:AKLIAkili Inc
06/03/20245:21PMEdgar (US Regulatory)Form SC TO-T - Tender offer statement by Third PartyNASDAQ:AKLIAkili Inc
05/29/20245:32PMEdgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:AKLIAkili Inc
05/29/20244:05PMEdgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:AKLIAkili Inc
05/29/20249:16AMEdgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:AKLIAkili Inc
05/29/20249:14AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKLIAkili Inc
05/29/20248:00AMBusiness WireVirtual Therapeutics, Akili Interactive Enter Into Definitive Merger Agreement to Establish Leading Digital Health CompanyNASDAQ:AKLIAkili Inc
05/14/20244:16PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AKLIAkili Inc
05/14/20244:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKLIAkili Inc
05/14/20244:01PMBusiness WireAkili Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:AKLIAkili Inc
05/06/20245:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKLIAkili Inc
04/30/20248:00AMBusiness WireAkili Announces Amended Agreement with Shionogi, Shift in Corporate Strategy and Release Date for First Quarter 2024 Financial ResultsNASDAQ:AKLIAkili Inc
03/06/20244:28PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:AKLIAkili Inc
03/06/20244:11PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AKLIAkili Inc
03/06/20244:07PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AKLIAkili Inc
02/29/20244:01PMBusiness WireAkili Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:AKLIAkili Inc
02/27/20242:00AMBusiness WirePureTech Founded Entity Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx ® for Pediatric ADHD Patients in JapanNASDAQ:AKLIAkili Inc
02/26/20249:04AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKLIAkili Inc
02/26/20248:47AMBusiness WireAkili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx® for Pediatric ADHD Patients in JapanNASDAQ:AKLIAkili Inc
02/23/20245:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKLIAkili Inc
02/23/20245:28PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AKLIAkili Inc
02/23/20247:57AMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:AKLIAkili Inc
02/21/20244:11PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKLIAkili Inc
02/21/20244:05PMBusiness WireAkili Announces Release Date for Fourth Quarter and Full Year 2023 Financial Results, Provides Investor Communications and Board and Corporate Governance UpdatesNASDAQ:AKLIAkili Inc
01/05/20244:17PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKLIAkili Inc
12/20/20234:58PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKLIAkili Inc
12/18/20238:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKLIAkili Inc
12/18/20238:00AMBusiness WireEndeavorRxⓇ, World’s First and Only Prescription Video Game Treatment, Secures FDA Label Expansion for Pediatric ADHD Patients Aged 13-17NASDAQ:AKLIAkili Inc
12/08/20235:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKLIAkili Inc
 Showing the most relevant articles for your search:NASDAQ:AKLI

Your Recent History

DBI
I1VG
XTIIIBEGVYUSDINAV
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved